MENU
+Compare
GDOC
ETF ticker: NYSE ARCA
AS OF
Nov 18 closing price
Price
$35.80
Change
-$0.01 (-0.03%)
Net Assets
21.54M

GDOC stock forecast, quote, news & analysis

The investment seeks long-term growth of capital... Show more

Category: #Health
GDOC
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for GDOC with price predictions
Nov 18, 2025

GDOC in -0.55% downward trend, sliding for three consecutive days on November 18, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where GDOC declined for three days, in of 215 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

GDOC broke above its upper Bollinger Band on November 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for GDOC just turned positive on November 06, 2025. Looking at past instances where GDOC's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GDOC advanced for three days, in of 214 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 203 cases where GDOC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), ABBVIE (NYSE:ABBV), Unitedhealth Group (NYSE:UNH), AstraZeneca PLC (NASDAQ:AZN), Merck & Co (NYSE:MRK), Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Exact Sciences Corp (NASDAQ:EXAS), Align Technology (NASDAQ:ALGN).

Industry description

The investment seeks long-term growth of capital. The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments in U.S. and non‑U.S. health care companies. The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare. The fund is non-diversified.

Market Cap

The average market capitalization across the Goldman Sachs Future Health Care Eq ETF ETF is 82.38B. The market cap for tickers in the group ranges from 950.06M to 921.91B. LLY holds the highest valuation in this group at 921.91B. The lowest valued company is MLTX at 950.06M.

High and low price notable news

The average weekly price growth across all stocks in the Goldman Sachs Future Health Care Eq ETF ETF was -0%. For the same ETF, the average monthly price growth was 7%, and the average quarterly price growth was 17%. MLTX experienced the highest price growth at 14%, while VEEV experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the Goldman Sachs Future Health Care Eq ETF ETF was 17%. For the same stocks of the ETF, the average monthly volume growth was 27% and the average quarterly volume growth was 111%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 61
Price Growth Rating: 45
SMR Rating: 57
Profit Risk Rating: 71
Seasonality Score: 39 (-100 ... +100)
View a ticker or compare two or three
GDOC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
Goldman Sachs ETF Trust200 West StreetNew York
Phone
N/A
Web
N/A